2016 in brief

Novo is a world-leading life science investor with a focus on creating long-term value.

Novo divides its Life Science Investments into three distinct areas: Large Investments focuses on established companies; Novo Ventures focuses on venture investments primarily in the US and Europe; and Novo Seeds focuses on early start ups primarily in the Nordic region and in Europe.

By the end of 2016, Novo had DKK 37.7 billion allocated to life science investments.